132 - Patricia Bradley CCO: Neurotech Series - MindMaze, Commercialise Neurotechnology

Let us know your thoughts. Send us a Text Message. Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn. Episode Title:- 🇨🇭Commercialise Neurotechnology🇨🇭In this #HTNeurotechSeries episode of Heads Talk, I am joined by Patricia Bradley, Global Chief Commercial Officer of MindMaze and this was a conversation about ‘go to market’ and the unique complexities for a Neurotech startup as opposed to other technology startups in the, for example, financial space.  Definitely one for those of you with a Neurotech startup, ready to scale up enterprise. A bit about MindMaze: It is a Neurotechnology company that famously became the 1st Swiss unicorn, when in 2016 it raised $100 million Dollars in Series A1 funding. Topics Covered:Neurotech InvestorsEcosystem (Lack of)Commercialised Components to Clinical TrialsReimbursement IssuesThe PitchCollaboration with Pharmaceutical CompaniesSo download⏳grab a cup of Bird & Blend Tea Co - Enchanted Nania Tea ☕️& have a listen🛋Series Sponsored by - PrivCap Resource GroupSeries Partnered with Foresight InstituteNext week's guest announced on LinkedIn every Monday. Follow me to see. ABOUT THE HOSTHeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeriesMindMaze Testimonials: https://mindmaze.com/testimonials/Support the showFollow, Support, Contact Heads Talk® - A Fly On The Boardroom WallLinkedInWebsiteTwitterEmail at [email protected]